Crossmark

Safety and survival associated with biologic therapies: first report of the Biobadaguay on the Paraguayan-Uruguayan registry of adverse events with biologic therapies

Crossref DOI link: https://doi.org/10.1016/j.reumae.2018.08.010

Published Print: 2020-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

de Abreu, Paloma

Ávila-Pedretti, Gabriela

Morel, Zoilo

Acosta, María Isabel

Cabrera-Villalba, Sonia

Melgarejo, Patricia

Franco, Marcos

Delgadillo, Pedro

Román, Lourdes

Elizaur, Juan Gabriel

Paredes, Ernesto

Cordobilla, Darwin Octavio

Palleiro, Daniel

Albanese, Miguel

Mazzoleni, Julio
License Information

Text and Data Mining valid from 2020-09-01
More Information

This article is maintained by: Elsevier

Article Title: Safety and survival associated with biologic therapies: first report of the Biobadaguay on the Paraguayan-Uruguayan registry of adverse events with biologic therapies

Journal Title: Reumatología Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reumae.2018.08.010

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.reuma.2018.08.009

Content Type: article

Copyright: © 2018 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.

Document is current

Any future updates will be listed below